Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

NCT06810544 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

191

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer
Glioma Glioblastoma Multiforme
Glioma, Malignant
Solid Tumor
Non-Small Cell Adenocarcinoma
Lung Cancer
Brain Tumor

Interventions

DRUG: TNG456
DRUG: abemaciclib

Sponsor

Tango Therapeutics, Inc.

Collaborators

[object Object]